Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 15Active not recruiting 10Not yet recruiting 3Withdrawn 1Available 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 1

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 86Bevacizumab 66Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 40Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34lenvatinib 27Cisplatin 27HMPL-013 25S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 20toripalimab 19Paclitaxel 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × balstilimab × Gastrointestinal × Clear all
NCT07595874 2026-05-27

NEST3

City of Hope Medical Center

Phase 2 Not yet recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT07551596 2026-05-15

Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07550088 2026-04-24

BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases

Scripps Health

Phase 2 Not yet recruiting
17 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡